Company Filing History:
Years Active: 2003-2004
Title: Suslonov Vladimir Michailovich: Innovator in Tuberculosis Treatment
Introduction
Suslonov Vladimir Michailovich is a prominent inventor based in Perm, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tuberculosis. With a total of 2 patents, his work focuses on developing novel compounds that serve as bacteriostatic agents against mycobacteria.
Latest Patents
His latest patents include innovative classes of methyl esters and benzoxazine compounds. The first patent, titled "Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis," discloses a novel class of compounds that exhibit surprising properties as bacteriostatic agents. These compounds include 4-(4-Ethoxy-phenyl)-2-(N′-fluoren-9-ylidene-hydrazino)-4-oxo-but-2-enoic acid methyl ester and 2-(4-Bromo-phenylamino)-5,5-dimethyl-4-oxo-hex-2-enoic acid methyl ester. The second patent, "2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis," reveals compounds that also act as bacteriostatic agents against mycobacteria, including 4-benzoyl-3-benzoyloxy-2-(2-oxo-2H-1,4-benzoxazin-3-yl)pyrido[2,1-c][1,4]benzoxazin-1,5-dione.
Career Highlights
Suslonov is affiliated with the University of Central Florida Research Foundation, Inc., where he continues to advance his research in pharmaceutical innovations. His work has garnered attention for its potential impact on treating tuberculosis, a disease that remains a significant global health challenge.
Collaborations
He collaborates with notable colleagues, including D Howard Miles and Krasnykh Olga Petrovna, who contribute to his research endeavors.
Conclusion
Suslonov Vladimir Michailovich stands out as an innovative inventor dedicated to developing effective treatments for tuberculosis. His contributions through his patents reflect a commitment to addressing critical health issues through scientific research and collaboration.